PMGC (NASDAQ:ELAB) Posts Quarterly Earnings Results

PMGC (NASDAQ:ELAB) released its quarterly earnings data on Monday. The company reported ($52.76) earnings per share (EPS) for the quarter, FiscalAI reports. The firm had revenue of $0.30 million during the quarter.

PMGC Stock Up 113.2%

Shares of NASDAQ:ELAB opened at $3.56 on Tuesday. The firm has a market cap of $1.92 million, a P/E ratio of -0.01 and a beta of 1.13. PMGC has a 12-month low of $1.62 and a 12-month high of $466.20. The business has a fifty day simple moving average of $9.18 and a 200 day simple moving average of $72.62.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of PMGC in a research report on Monday, December 29th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock has an average rating of “Sell”.

PMGC Company Profile

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.